Unraveling the fertility knot in World Health Organization type 2 anovulatory women Another step toward a pharmacogenetic treatment choice

Authors:
Manuela Simoni, M.D., Ph.D.

Volume 103, Issue 4, Pages 900-901

Abstract:
Reflections on “FSH receptor polymorphism affects the outcome of ovulation induction in normogonadotropic (WHO2) anovulatory infertility” by Valkenburg et al.

Translate »